OBESITY AND ITS RELATIONSHIP WITH CANCER: PART II CANCER
Article Sidebar
Main Article Content
Abstract
This four-part manuscript briefly reviews the association of obesity with cancer. Part I discussed obesity while this (Part II) will discuss obesity and its impact on cancer. Part III and Part IV will review the association of obesity on fourteen common cancers.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Adams TD, Stroup AM, Gress RE, et al. (2009). Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring) 17:796-802.
Allott E.H., Masko E.M., (2013) Freedland S.J. Obesity and prostate cancer: Weighing the evidence. Eur. Urol. 63:800–809. doi: 10.1016/j.eururo.2012.11.013.
Alsamarrai A, Das SL, Windsor JA, Petrov MS. (2014) Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 12: 1635-44. :quiz e103.
Amankwah E, Saenz A, Hale G, Brown P. (2016) Association between body mass index at diagnosis and pediatric leukemia mortality and relapse: a systematic review and meta-analysis. Leukemia Lymphoma 57:1140–8.
Anand P, Kunnumakkara AB, Sundaram C, et al. (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. (9):2097–116. 10.1007/s11095-008-9661-9.
Annett S, Moore G, Robson T. (2020) Obesity and Cancer Metastasis: Molecular and Translational Perspectives. Cancers (Basel).12(12):3798. Published 2020 Dec 16. doi:10.3390/cancers12123798.
Arnold M., Renehan A.G., Colditz G.A. (2017) Excess weight as a risk factor common to many cancer sites: Words of caution when interpreting meta-analytic evidence. Cancer Epidemiol. Biomark. Prev. 26:663–665. doi: 10.1158/1055-9965.EPI-16-0940.
Aune D, Sen A, Prasad M, et al. (2016) BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 353:i2156.
Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. (2019) Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism. Mar;92:121-135. doi: 10.1016/j.metabol.2018.11.001.
Bachmann J, Heiligensetzer M, Krakowski-Roosen H, et al. (2008) Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg. 12(7):1193.
Bhaskaran K., Douglas I., Forbes H., et al. (2014). Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet, 384, 755-765.
Behrens G., Gredner T., Stock C., et al. (2018). Cancers Due to Excess Weight, Low Physical Activity, and Unhealthy Diet. Dtsch Arztebl Int, 115(35-36). 578-585. https://doi:10.3238/arztebl.2018.0578.
Beral V., Hermon C., Peto R., et al. (2012) Ovarian cancer and body size: Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med. doi: 10.1371/journal.pmed.1001200.
Birks S, Peeters A, Backholer K, O'Brien P & Brown W (2012) A systematic review of the impact of weight loss on cancer incidence and mortality. Obes Rev 13, 868–891.
Boutari C, Mantzoros CS. (2018) Inflammation: A key player linking obesity with malignancies. Metabolism 81:A3-a6.
Brown K.F., Rumgay H., Dunlop C., et al. (2015). The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer, 118(8), 1130-1141. https://doi:10.1038/s41416-018-0029-6.
Calle E.E., C. Rodriguez, K. Walker-Thurmond, M.J. Thun. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348, pp. 1625-1638.
Capocaccia R, Gatta G, Dal Maso L. (2015) Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data. Ann Oncol. 26(6):1263–1268. doi: 10.1093/annonc/mdv131.
Castagneto-Gissey L., Casella-Mariolo J., Casella G., Mingrone G. (2020) Obesity Surgery and Cancer: What Are the Unanswered Questions? Front. Endocrinol. 11:213. doi: 10.3389/fendo.2020.00213.
Cespedes Feliciano EM, Kroenke CH, Caan BJ. (2018) The Obesity Paradox in Cancer: How Important Is Muscle? Annu Rev Nutr. 38:357–379.
Christou NV, Lieberman M, Sampalis F, Sampalis JS. (2008) Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis 4:691-5.
Cnop M, Havel PJ, Utzschneider KM, et al. (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459-69.
Cogliano VJ, Baan R, Straif K, et al. (2011) Preventable exposures associated with human cancers. Journal of the National Cancer Institute. 103(24):1827–39. doi: 10.1093/jnci/djr483.
Cong L, Gasser J, Zhao J, Yang B, Li F, Zhao AZ. (2007) Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Endocr Relat Cancer. Sep;14(3):713-20. doi: 10.1677/ERC-07-0065
Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. (2010) Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19:3119-30.
De Pergola G, Silvestris F. (2013) Obesity as a major risk factor for cancer. J Obes. 2013:291546. doi:10.1155/2013/291546
DeWys. W.D. (1977) Anorexia in Cancer Patients.Cancer Res July 1 (37) (7 Part 2) 2354-2358.
Diamantis G, Scarpa M, Bocus P, et al. (2011). Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia. World J Gastroenterol. Jan 14;17(2):144-50. doi: 10.3748/wjg.v17.i2.144.
Djuric Z. (2017) Obesity‐associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state. Transl Res. 179: 155‐ 167.
Ehrsson YT, Fransson P, Einarsson S. (2021) Mapping Health-Related Quality of Life, Anxiety, and Depression in Patients with Head and Neck Cancer Diagnosed with Malnutrition Defined by GLIM. Nutrients. Apr 1;13(4):1167. doi: 10.3390/nu13041167.
Emerenziani S, Rescio MP, Guarino MP, Cicala M. (2013) Gastro-esophageal reflux disease and obesity, where is the link? World J Gastroenterol 19:6536-9.
Feng, RM., Zong, YN., Cao, SM. et al. (2019) Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?. Cancer Commun 39, 22. https://doi.org/10.1186/s40880-019-0368-6.
Ferlay J, Ervik M, Lam F, et al. (2020) Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; (https://gco.iarc.fr/today, accessed February 2021.
Fernandez CJ, George AS, Subrahmanyan NA, Pappachan JM. (2021) Epidemiological link between obesity, type 2 diabetes mellitus and cancer. World J Methodol. May 20;11(3):23-45. doi: 10.5662/wjm.v11.i3.23.
Islam, K. M. A., Khan, M. A. U., Azhar, S., Ahmed, M. R., Khurram, S., Masood, H., & Farooq, L. (2020). Comparison Of In Vitro Activity of Colistin with Ceftolozane/Tazobactam against Multi Drug Resistant Pseudomonas Aeruginosa “A Last Line Treatment against Mdr”. American International Journal of Multidisciplinary Scientific Research, 6(3), 1-7.
Gallagher EJ, LeRoith D. (2015) Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. Physiol Rev 95:727-48.
García-Jiménez C, Gutiérrez-Salmerón M, Chocarro-Calvo A, et al. (2016) From obesity to diabetes and cancer: epidemiological links and role of therapies. Br J Cancer. 114:716–722.
Genkinger J.M., Spiegelman D., Anderson K.E., et al. (2011) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int. J. Cancer. 129:1708–1717. doi: 10.1002/ijc.25794.
Gómez de Cedrón M, Ramírez de Molina A. (2019) Chapter 28 - Precision nutrition to target lipid metabolism alterations in cancer. In: Faintuch J, Faintuch S. editors. Precision Medicine for Investigators, Practitioners Providers. Academic Press. p. 291–9. 10.1016/B978-0-12-819178-1.00028-9.
Gutiérrez-Salmerón M, Chocarro-Calvo A, García-Martínez JM, de la Vieja A, García-Jiménez C. (2017) Epidemiological bases and molecular mechanisms linking obesity, diabetes, and cancer. Endocrinol Diabetes Nutr. 64:109–117.
Howlader N, Noone AM, Krapcho M, et al. (eds). (2021) SEER Cancer Statistics Review, 1975–2018. National Cancer Institute, posted to the SEER website, April. Accessed April 19, 2021.
https://gco.iarc.fr/today/data/factsheets/populations/935-asia-fact-sheets.pdf - accessed May 30, 2021.
Hu MB, Xu H, Bai PD, Jiang HW, Ding Q. (2014) Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response meta-analysis of 36,927 patients. Med Oncol. 31:829.
Hursting SD, Berger NA. (2010) Energy balance, host-related factors, and cancer progression. J Clin Oncol. 28:4058–65.
Islami, F., Goding Sauer, A., Miller, K.D., et al. (2018). Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA: A Cancer Journal for Clinicians, 68, 31-54. https://doi:10.3322/caac.21440.
Keum N, Greenwood DC, Lee DH, et al. (2015) Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. Journal of the National Cancer Institute 107(2). pii: djv088.
Key TJ, Appleby PN, Reeves GK, et al. (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218-26.
Lan N, Lu Y, Zhang Y, et al. (2020) FTO - A Common Genetic Basis for Obesity and Cancer. Front Genet. Nov 16;11:559138. doi: 10.3389/fgene.2020.559138.
Lauby-Secretan B., Scoccianti C., Loomis D., et al. (2016). Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med, 375, 794–8.
Lee DH, Giovannucci EL (2019) The Obesity Paradox in Cancer: Epidemiologic Insights and Perspectives. Curr Nutr Rep. 8:175–181.
Lengyel E., Makowski L., DiGiovanni J., Kolonin M.G. (2018) Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors. Trends Cancer. 4:374–384. doi: 10.1016/j.trecan.2018.03.004.
Lin XJ, Wang CP, Liu XD, et al. (2014) Body mass index and risk of gastric cancer: a meta-analysis. Jpn J Clin Oncol. 44:783–791.
Liu X, Xue Z, Yu J, Li Z, Ma Z, Kang W, Ye X, Jiang L. (2020) Risk Factors for Postoperative Infectious Complications in Elderly Patients with Gastric Cancer. Cancer Manag Res. Jun 9;12:4391-4398. doi: 10.2147/CMAR.S253649.
Manna P., Jain S.K. (2015) Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab. Syndr. Relat. Disord. 13(10):423–444. doi: 10.1089/met.2015.0095.
Manousos O, Souglakos J, Bosetti C, et al. (1999) IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer 83:15-7.
Martin L, Birdsell L, Macdonald N, et al. (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31 (12): 1539-47.
Moodi M, Tavakoli T, Tahergorabi Z. (2021) Crossroad between Obesity and Gastrointestinal Cancers: A Review of Molecular Mechanisms and Interventions. Int J Prev Med. Feb 24;12:18. doi: 10.4103/ijpvm.IJPVM_266_20.
Morris PG, Hudis CA, Giri D, et al. (2011) Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila). Jul;4(7):1021-9. doi: 10.1158/1940-6207.CAPR-11-0110.
Muliawati Y, Haroen H, Rotty LW. (2012) Cancer anorexia - cachexia syndrome. Acta Med Indones. Apr;44(2):154-62
Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. (2014) Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev. 36:114–136.
Naito T, Okayama T, Aoyama T, et al. (2017) Unfavourable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study. BMC Cancer. 17(1):800.
NCI (2020), National Cancer Institute Cancer Trends Progress Report: Life After Cancer. Accessed August 15, 2020.
Ogle, K.S., Swanson, G.M., Woods, N. and Azzouz, F. (2000), Cancer and comorbidity. Cancer, 88: 653-663. https://doi.org/10.1002/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1.
Okabayashi K, Ashrafian H, Hasegawa H, (2012) Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. 107:1175–85; quiz 1186.
Olsen CM, Green AC, Whiteman DC, et al. (2007) Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer. 43:690–709.
Parker ED, Folsom AR. (2003) Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study. Int J Obes Relat Metab Disord 27:1447-52.
Parto P, Lavie CJ. (2017)Obesity and CardiovascularDiseases. Curr Probl Cardiol. Nov;42(11):376-394. doi: 10.1016/j.cpcardiol.2017.04.004.
Petrelli F, Cortellini A, Indini A, Tomasello G, Zaniboni A. (2020) Obesity paradox in patients with cancer: A systematic review and meta-analysis of 6,320,365 patients. medRxiv 04.28. 20082800.
Pi-Sunyer X. (2009) The medical risks of obesity. Postgrad Med. 121:21–33.
Postma EM, Kok DE, de Graaf C, Kampman E, Boesveldt S. (2020) Chemosensory perception and food preferences in colorectal cancer patients undergoing adjuvant chemotherapy. Clin Nutr ESPEN. Dec;40:242-251. doi: 10.1016/j.clnesp.2020.09.012
Qin Q, Xu X, Wang X, Zheng XY. (2013) Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Asian Pac J Cancer Prev. 14:3117–3121.
Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-53.
Rock CL, Doyle C, Demark-Wahnefried W, et al. (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 62:243–274.
Roila F., Herrstedt J., Aapro M., et al. (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Annals of Oncology. 21(5):v232–v243. doi: 10.1093/annonc/mdq194.
Rui R, Lou J, Zou L, et al. (2012) Excess body mass index and risk of liver cancer: a nonlinear dose-response meta-analysis of prospective studies. PLoS One. 7:e44522.
Ryan AM, Prado CM, Sullivan ES, Power DG, Daly LE. (2019) Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition. Nov-Dec;67-68:110539. doi: 10.1016/j.nut.2019.06.020.
Sabharwal SS, Schumacker PT. (2014) Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat Rev Cancer 14:709-21.
Sang Min Park, Young Ho Yun, Young Ae Kim, et al. (2016). Prediagnosis Body Mass Index and Risk of Secondary Primary Cancer in Male Cancer Survivors: A Large Cohort Study. Journal of Clinical Oncology, 34, 4116-4124.
Schauer D.P., Feigelson H.S., Koebnick C., et al. (2019) Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort. Ann. Surg. 269:95–101. doi: 10.1097/SLA.0000000000002525.
Schmitz KH, Neuhouser ML, Agurs-Collins T, et al. (2013) Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. Journal of the National Cancer Institute 105(18):1344-1354.
Schnurr T.M., Jakupović H., Carrasquilla G.D., et al. (2020) Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: A case-cohort study. Diabetology. 63:1324–1332. doi: 10.1007/s00125-020-05140-5.
Shafi MA. (2019) Gastrointestinal Motility Issues in Cancer Patients. Curr Gastroenterol Rep. Dec 10;21(12):69. doi: 10.1007/s11894-019-0738-x.
Shaw E, Farris M, McNeil J, Friedenreich C. (2016) Obesity and Endometrial Cancer. Recent Results Cancer Res 208:107-36.
Steeg P.S.. (2016) Targeting metastasis. Nat. Rev. Cancer, 16 (4), p. 201.
Steele C.B., Thomas C.C., Henley S.J., et al. (2017) Vital signs: Trends in incidence of cancers associated with overweight and obesity-United States, 2005–2014. MMWR Morb. Mortal. Wkly. Rep. 66:1052–1058. doi: 10.15585/mmwr.mm6639e1.
Stienstra R, Tack CJ, Kanneganti TD, Joosten LA, Netea MG. (2012) The inflammasome puts obesity in the danger zone. Cell Metab 15:10-8.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. May;71(3):209-249. doi: 10.3322/caac.21660.
Wadasadawala T, Sen S, Watekar R, et al. (2021) Economic Distress of Breast Cancer Patients Seeking Treatment at a Tertiary Cancer Center in Mumbai during COVID-19 Pandemic: A Cohort Study. Asian Pac J Cancer Prev. 22(3):793-800. Published 2021 Mar 1. doi:10.31557/APJCP.2021.22.3.793.
Wang F, Xu Y. (2104) Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies. Int J Cancer. 135:1673–1686.
Webster JM, Kempen LJAP, Hardy RS, Langen RCJ. (2020) Inflammation and Skeletal Muscle Wasting During Cachexia. Front Physiol. Nov 19;11:597675. doi: 10.3389/fphys.2020.597675.
Włodarczyk M., Nowicka G. (2019) Obesity, DNA damage, and development of obesity-related diseases. Int. J. Mol. Sci. 20(5):E1146. doi: 10.3390/ijms20051146
Wolk A, Mantzoros CS, Andersson SO, et al. (1998) Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 90:911- 5.
WHO (2020). World Health Organization. Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. Accessed December 11, 2020. who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death.
www. cancer.gov.
www.health.harvard.edu.
www.iarc.who.int.
https://www.usa.gov/federal-agencies/national-cancer-institute.
www.who.int
Yang Y, Dong J, Sun K, et al. (2013) Obesity and incidence of lung cancer: a meta-analysis. Int J Cancer. 132:1162–1169.
Zhang Y, Liu H, Yang S, Zhang J, Qian L, Chen X. (2014). Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis. Int J Biol Markers. 29:e21–e29.
Zhao ZG, Guo XG, Ba CX, (2012). Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res. 2012;40:2041–2050.